This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Jan;65(1):3-4.

doi: 10.1016/j.maturitas.2009.11.002. Epub 2009 Nov 22.

Bisphosphonates and atypical femoral fractures: a time for reflection

PMID: 19932574
DOI: 10.1016/j.maturitas.2009.11.002

Editorial

Bisphosphonates and atypical femoral fractures: a time for reflection

J E Compston. Maturitas. 2010 Jan.

. 2010 Jan;65(1):3-4.

doi: 10.1016/j.maturitas.2009.11.002. Epub 2009 Nov 22.

Author

PMID: 19932574
DOI: 10.1016/j.maturitas.2009.11.002

No abstract available

PubMed Disclaimer

Similar articles

What to make of the new warning on bisphosphonates. Officials acknowledge a connection between the most popular bone drugs and rare thigh fractures.
[No authors listed] [No authors listed] Harv Womens Health Watch. 2010 Dec;18(4):6-7. Harv Womens Health Watch. 2010. PMID: 21268797 No abstract available.
Thighbone fractures in women taking bisphosponate drugs.
[No authors listed] [No authors listed] Harv Womens Health Watch. 2010 Mar;17(7):6-7. Harv Womens Health Watch. 2010. PMID: 20486271 No abstract available.
More on atypical fractures of the femoral diaphysis.
Lee P, Seibel MJ. Lee P, et al. N Engl J Med. 2008 Jul 17;359(3):317; author reply 317-8. N Engl J Med. 2008. PMID: 18642421 No abstract available.
Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?
McClung M. McClung M. Clin Obstet Gynecol. 2013 Dec;56(4):743-8. doi: 10.1097/GRF.0b013e3182a98295. Clin Obstet Gynecol. 2013. PMID: 24177063 Review.
[Bisphosphonates for osteoporosis].
Narusawa K, Nakamura T. Narusawa K, et al. Nihon Rinsho. 2007 Nov 28;65 Suppl 9:311-5. Nihon Rinsho. 2007. PMID: 18161123 Review. Japanese. No abstract available.

See all similar articles

Cited by

We need a break: Bisphosphonates.
Jaiman A, Sabat D, Arora S, Hafez MA. Jaiman A, et al. J Clin Orthop Trauma. 2013 Mar;4(1):11-4. doi: 10.1016/j.jcot.2013.01.010. Epub 2013 Feb 6. J Clin Orthop Trauma. 2013. PMID: 26403770 Free PMC article. Review.
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.
Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J. Brown JP, et al. Can Fam Physician. 2014 Apr;60(4):324-33. Can Fam Physician. 2014. PMID: 24733321 Free PMC article. Review.
New understanding and treatments for osteoporosis.
Mazziotti G, Bilezikian J, Canalis E, Cocchi D, Giustina A. Mazziotti G, et al. Endocrine. 2012 Feb;41(1):58-69. doi: 10.1007/s12020-011-9570-2. Endocrine. 2012. PMID: 22180055 Review.
Teriparatide for the rapid resolution of delayed healing of atypical fractures associated with long-term bisphosphonate use.
Mastaglia SR, Aguilar G, Oliveri B. Mastaglia SR, et al. Eur J Rheumatol. 2016 Jun;3(2):87-90. doi: 10.5152/eurjrheum.2015.0010. Epub 2015 Aug 21. Eur J Rheumatol. 2016. PMID: 27708978 Free PMC article.
Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation.
Kinov P, Boyanov M. Kinov P, et al. Int J Womens Health. 2012;4:167-74. doi: 10.2147/IJWH.S18209. Epub 2012 Apr 12. Int J Womens Health. 2012. PMID: 22532780 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information